NCT04900597

Brief Summary

Blenderized diets consist of a wide range of table foods such as fruits, vegetables, meat and legumes, pureed in a blender and administered via gastrostomy tube. In a recent study, the investigators reported that children receiving blenderized feeds via gastrostomy had fewer total admissions and respiratory admissions, total emergency room visits, and improved gastrointestinal symptom scores compared to those fed formula. The goal of this project is to understand how these diets affect gastroesophageal reflux burden.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Aug 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Aug 2021Dec 2026

First Submitted

Initial submission to the registry

May 18, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 25, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2021

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

March 30, 2026

Status Verified

March 1, 2026

Enrollment Period

4.9 years

First QC Date

May 18, 2021

Last Update Submit

March 25, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Reflux episodes

    Number of total reflux episodes (acid and non-acid) by impedance

    4 hours (following feed)

Secondary Outcomes (4)

  • Full column reflux episodes

    4 hours (following feed)

  • Percent of time esophageal pH < 4

    4 hours after feed

  • Average height of refluxate

    4 hours after feed

  • Number of symptoms

    4 hours after feed

Other Outcomes (1)

  • Gastric emptying (percent of ingested contents remaining in stomach at 1 hour)

    1 hour

Study Arms (3)

Elecare - Nourish - Real Foods Blends

EXPERIMENTAL

Elecare for first bolus, Nourish for second bolus, Real Foods Blends for third bolus

Other: Elecare JrOther: NourishOther: Real Foods Blends

Nourish - Real Foods Blends - Elecare

EXPERIMENTAL

Nourish for first bolus, Real Foods Blends for second bolus, Elecare for first bolus

Other: Elecare JrOther: NourishOther: Real Foods Blends

Real Foods Blends - Elecare - Nourish

EXPERIMENTAL

Real Foods Blends for first bolus, Elecare for second bolus, Nourish for third bolus

Other: Elecare JrOther: NourishOther: Real Foods Blends

Interventions

NourishOTHER

Nourish is a commercially prepared blenderized tube feed that is formulated for pediatric use

Elecare - Nourish - Real Foods BlendsNourish - Real Foods Blends - ElecareReal Foods Blends - Elecare - Nourish

Real Foods Blends is a commercially prepared blenderized tube feed that is formulated for pediatric use

Elecare - Nourish - Real Foods BlendsNourish - Real Foods Blends - ElecareReal Foods Blends - Elecare - Nourish

Elecare Jr is a standard pediatric elemental formula

Elecare - Nourish - Real Foods BlendsNourish - Real Foods Blends - ElecareReal Foods Blends - Elecare - Nourish

Eligibility Criteria

Age1 Year+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Age 1-21 years
  • G-tube
  • Able to tolerate bolus gastric feeds over 30 minutes
  • Use of conventional enteral formula
  • Undergoing impedance study for clinical purposes

You may not qualify if:

  • History of allergy or intolerance to any component of the test diets
  • History of Nissen fundoplication (participants with suspected or documented unwrapped fundoplication will be eligible for participation)
  • Current use of non-invasive pressure support (continuous or bi-level positive airway pressure)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Boston Children's Hospital

Boston, Massachusetts, 02115, United States

RECRUITING

Study Officials

  • Bridget M Hron, MD

    Boston Children's Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Staff Physician

Study Record Dates

First Submitted

May 18, 2021

First Posted

May 25, 2021

Study Start

August 1, 2021

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

March 30, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations